Abstract (eng)
There were two HPLC column-switching methods worked out for the enantioselective separation and determination of (R)- and (S)-carvedilol in plasma. A deproteinization of plasma was carried out either by feeding a dilute of, acidified plasma sample to a LiChrospher ® ADS RP4 column, or by liquid-liquid extraction and back extraction with trichloromethane in 0.1 M citric acid. In both cases, a preliminary separation was performed using gradient elution on the carvedilol group and subsequently transferred "on-line" to an enantioselective Teicoplanin column. The separation of the enantiomers of carvedilol was carried out isocratically with an eluent mixture of methanol-acetonitrile-triethylammonium (70:30:0,05, v / v / w) as the mobile phase.
With the fluorescence detection used, a quantification limit of 0.30 ng / mL for (R)-carvedilol and 0.26 ng / mL for (S)-carvedilol was reached.
Although the conditions for an "on-line" pre-separation of plasma proteins using a LiChrospher ® RP-18 ADS column were optimized, the elaborated method was not stable enough for the analysis of a large number of plasma samples. The transfer of plasma components during the switching interval, led to a progressive deterioration of the enantioselective separation efficiency of the teicoplanin column. Alternatively, a liquid-liquid extraction method with subsequent multi-column chromatography was developed. This method proved in practice to be stable and robust for the analysis of a large number of plasma samples.